A prospective open-label, single treatment study to assess the safety and the performance of the Nyxoah SAT system for the treatment of Obstructive Sleep Apnea

Inclusion Criteria:

• Diagnosed with moderate to severe Obstructive Sleep Apnea
• Have failed or have not tolerated CPAP treatment
• Willing and capable of providing informed consent
• Willing and capable of returning to all follow-up visits and sleep studies, including evaluation procedures and filling out questionnaires

Exclusion Criteria:

• BMI limits
• Subjects with complete concentric collapse at the soft palate level per endoscopy